Literature DB >> 20974862

Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Joanne L Fothergill1, Eilidh Mowat, Martin J Walshaw, Martin J Ledson, Chloe E James, Craig Winstanley.   

Abstract

Phage production in response to antibiotics varied among four isolates of a Pseudomonas aeruginosa cystic fibrosis (CF) epidemic strain. Whereas ciprofloxacin induced higher levels of phage production, other CF-relevant antibiotics led to reduced production. We detected free phages directly in CF patient sputum samples by both plaque (40% positive) and PCR (76% positive) assays. Our observations suggest that the choice of antibiotics could influence the number of free phages within the CF lung environment.

Entities:  

Mesh:

Year:  2010        PMID: 20974862      PMCID: PMC3019632          DOI: 10.1128/AAC.01257-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

2.  Action of colistin (polymyxin E) on the lytic cycle of the mycobacteriophage D29 in Mycobacterium tuberculosis.

Authors:  H L David; N Rastogi; S Clavel-Sérès; F Clément
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-09

3.  Oxidative stress during acute respiratory exacerbations in cystic fibrosis.

Authors:  L T McGrath; P Mallon; L Dowey; B Silke; E McClean; M McDonnell; A Devine; S Copeland; S Elborn
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

4.  Different classes of antibiotics differentially influence shiga toxin production.

Authors:  Colleen Marie McGannon; Cynthia Ann Fuller; Alison Ann Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

5.  A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection.

Authors:  Melissa E K Carter; Joanne L Fothergill; Martin J Walshaw; Kumar Rajakumar; Aras Kadioglu; Craig Winstanley
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

6.  Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.

Authors:  Joanne L Fothergill; Eilidh Mowat; Martin J Ledson; Martin J Walshaw; Craig Winstanley
Journal:  J Med Microbiol       Date:  2009-12-17       Impact factor: 2.472

7.  Increased frequency of genomic alterations in Staphylococcus aureus during chronic infection is in part due to phage mobilization.

Authors:  Christiane Goerke; Saskia Matias y Papenberg; Simone Dasbach; Klaus Dietz; Rita Ziebach; Barbara C Kahl; Christiane Wolz
Journal:  J Infect Dis       Date:  2004-01-29       Impact factor: 5.226

8.  Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.

Authors:  Fiona W Scott; Tyrone L Pitt
Journal:  J Med Microbiol       Date:  2004-07       Impact factor: 2.472

9.  Phage F-116 transduction of antibiotic resistance from a clinical isolate of Pseudomonas aeruginosa.

Authors:  J Blahová; M Hupková; V Krcméry
Journal:  J Chemother       Date:  1994-06       Impact factor: 1.714

10.  Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development.

Authors:  Jeremy S Webb; Mathew Lau; Staffan Kjelleberg
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

View more
  22 in total

1.  Phage-Antibiotic Synergy via Delayed Lysis.

Authors:  Minjin Kim; Yunyeol Jo; Yoon Jung Hwang; Hye Won Hong; Sung Sik Hong; Kwangseo Park; Heejoon Myung
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

2.  The NMR-Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope.

Authors:  Omry Morag; Nikolaos G Sgourakis; David Baker; Amir Goldbourt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-13       Impact factor: 11.205

3.  Methods for Extraction and Detection of Pf Bacteriophage DNA from the Sputum of Patients with Cystic Fibrosis.

Authors:  Elizabeth B Burgener; Patrick R Secor; Michael C Tracy; Johanna M Sweere; Elisabeth M Bik; Carlos E Milla; Paul L Bollyky
Journal:  Phage (New Rochelle)       Date:  2020-06-16

Review 4.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 5.  Molecular Determinants of Antibiotic Resistance in the Costa Rican Pseudomonas aeruginosa AG1 by a Multi-omics Approach: A Review of 10 Years of Study.

Authors:  Jose Arturo Molina-Mora; Fernando García
Journal:  Phenomics       Date:  2021-06-17

6.  Liverpool Epidemic Strain Isolates of Pseudomonas aeruginosa Display High Levels of Antimicrobial Resistance during Both Planktonic and Biofilm Growth.

Authors:  Mara C Goodyear; Nicole E Garnier; Roger C Levesque; Cezar M Khursigara
Journal:  Microbiol Spectr       Date:  2022-06-06

7.  Temperate phages both mediate and drive adaptive evolution in pathogen biofilms.

Authors:  Emily V Davies; Chloe E James; David Williams; Siobhan O'Brien; Joanne L Fothergill; Sam Haldenby; Steve Paterson; Craig Winstanley; Michael A Brockhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

8.  Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities.

Authors:  Yan Wei Lim; Robert Schmieder; Matthew Haynes; Dana Willner; Mike Furlan; Merry Youle; Katelynn Abbott; Robert Edwards; Jose Evangelista; Douglas Conrad; Forest Rohwer
Journal:  J Cyst Fibros       Date:  2012-08-28       Impact factor: 5.482

9.  Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.

Authors:  Sebastian Kirchner; Joanne L Fothergill; Elli A Wright; Chloe E James; Eilidh Mowat; Craig Winstanley
Journal:  J Vis Exp       Date:  2012-06-05       Impact factor: 1.355

10.  Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.

Authors:  Chloe E James; Joanne L Fothergill; Amanda J Hall; Jennifer Cottell; Michael A Brockhurst; Craig Winstanley
Journal:  BMC Microbiol       Date:  2012-09-21       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.